higher for those who stayed on treatment HbA1c fell by 1.91 percentage points from a mean baseline of 8.2% 73.5% of participants reached HbA1c 6.5%, a normal blood sugar threshold Compared to 15.9% with placebo Diabetes patients typically lose less weight on GLP-1 drugs than non-diabetic patients this pattern holds with CagriSema
While you might not want to discard expired and unused semaglutide injections, its not worth the risk
However, deep down, I still yearned for even the slightest improvement
For instance, if your blood sugar is maintained within normal levels, the dosage may be lowered particularly if you are experiencing some minor side effects
Today, GLP-1 weight loss drugs are among the most talked-about medicines in the world, fuelled by celebrity culture, online hype, and a rapidly growing grey market